Hongri Pharmaceutical

Company Profile
Tianjin Hongri Pharmaceutical Co., Ltd. was established in 1996 and is one of the first batch of listed companies on the ChiNext board of the national stock market. After more than two decades of dedicated efforts, the company has become a high-tech pharmaceutical health industry cluster that spans multiple fields such as finished drugs, traditional Chinese medicine formula granules, raw and auxiliary materials, medical devices, medical health services, and smart supply chain for drugs and devices, integrating investment and financing, production, research and development, and sales. In recent years, the company has consistently ranked among the top 100 pharmaceutical enterprises in China. In 2020, its main business revenue reached 6.488 billion yuan, total assets were 10.18 billion yuan, and tax payments amounted to 540 million yuan. Hongri Pharmaceutical always stands at the forefront of technology, with technological innovation and industrialization of achievements as the source of continuous development. Relying on the two technology platforms established - the National Enterprise Technology Center and the National and Local Joint Engineering Research Center for Key Technologies of Traditional Chinese Medicine Formula Granules - and collaborating with renowned academicians such as Zhong Nanshan and Zhang Boli, the company continuously conducts innovative research on antitumor drugs, the treatment of COVID-19 with Xuebijing, and key technologies for the secondary development of Chinese patent medicines. Hongri Pharmaceutical has always regarded talent cultivation and development as the foundation of the enterprise. We have established an open and efficient communication platform. With a flat organizational structure, clear career advancement paths, performance management mechanisms, and talent incentive systems, we enable Hongri employees to create value and realize their ideals on this platform. Hongri Pharmaceutical has a comprehensive training system that provides sufficient human resources support for enterprise development; we cultivate elite, practical, and high-quality talents, adhering to the talent philosophy of "Competition over selection, achievement determines position." "Inherit and develop Chinese medicine, solve human health problems." Hongri Pharmaceutical will continue to practice the two value propositions of "Striving for the public to enjoy high-quality traditional Chinese medicine services!" and "Striving for the improvement of China's medical treatment level!" and strive to go global and reach the world!